基质金属蛋白酶19在结直肠癌及其肝转移中的作用与预后价值

doi:10.3969/j.issn.1006-5725.2025.13.007

Abstract

Abstract:

Objective To explore the function and molecular mechanisms of matrix metalloproteinase 19 （MMP-19） in colorectal cancer （CRC） and liver metastasis of CRC （CRLM）. Methods This study comprehensively analyzed transcriptomic data， single-cell data， and clinical information of CRC and CRLM patients retrieved from public databases， namely The Cancer Genome Atlas （TCGA） and Gene Expression Omnibus （GEO）. RNA sequencing analysis was carried out to identify biological functions associated with MMP-19 expression. The differential expression of MMP-19 between primary lesions and liver metastatic lesions was evaluated using quantitative real-time polymerase chain reaction （qRT-PCR）， Western blotting， and immunohistochemistry. In vitro functional assays were performed to validate the impact of MMP-19 on the proliferation， invasion， and migration of colorectal cancer cells. Results MMP-19 was highly expressed in CRC tissues and was significantly correlated with poor prognosis in both CRC and CRLM patients. Sequencing results and functional enrichment analysis demonstrated that MMP-19 is involved in epithelial-mesenchymal transition， amino acid and protein transport， cell proliferation， extracellular matrix organization， and the mitogen-activated protein kinase （MAPK） signaling pathway. Single-cell analysis revealed that the expression of MMP-19 in macrophages and dendritic cells was higher in both CRC primary tumors and liver metastases compared to normal tissues. In vitro experiments confirmed that MMP-19 enhances the proliferation， invasion， and migration capabilities of colorectal cancer cells. Conclusion MMP-19 has been shown to play a crucial role in promoting the development and progression of CRC. It increases the risk of postoperative recurrence and liver metastasis through inducing epithelial-mesenchymal transition and remodeling the immune microenvironment. Given these findings， MMP-19 emerges as a promising novel target for the diagnosis and treatment of both CRC and CRLM.

Key words: matrix metalloproteinases, colorectal cancer, colorectal cancer liver metastasis, epithelial-mesenchymal transition

CLC Number:

R735

Zeping HE,Junming XU. The role and prognostic value of matrix metalloproteinase 19 in colorectal cancer and its liver metastasis[J]. The Journal of Practical Medicine, 2025, 41(13): 1987-1996.

Figures/Tables 20

Fig.1

Fig.2

Tab.1

Tab.2

Fig.3

Tab.3

Tab.4

Fig.4

Tab.5

Tab.6

Tab.7

Tab.8

Tab.9

Tab.10

Tab.11

Tab.12

Tab.13

Tab.14

Tab.15

Tab.16

References 27

[1]	YAN C， SHAN F， LI Z Y. ［Prevalence of colorectal cancer in 2020： A comparative analysis between China and the world］［J］. Zhonghua Zhong Liu Za Zhi， 2023， 45（3）： 221-229.
[2]	ZHOU H， LIU Z， WANG Y， et al. Colorectal liver metastasis： Molecular mechanism and interventional therapy ［J］. Signal Transduct Target Ther， 2022， 7（1）： 70. doi:10.1038/s41392-022-00922-2 doi: 10.1038/s41392-022-00922-2
[3]	PETRONI G， BUQUE A， COUSSENS L M， et al. Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment ［J］. Nat Rev Drug Discov， 2022， 21（6）： 440-462. doi:10.1038/s41573-022-00415-5 doi: 10.1038/s41573-022-00415-5
[4]	PEZESHKIAN Z， NOBILI S， PEYRAVIAN N， et al. Insights into the Role of Matrix Metalloproteinases in Precancerous Conditions and in Colorectal Cancer ［J］. Cancers （Basel）， 2021， 13（24）：6226. doi:10.3390/cancers13246226 doi: 10.3390/cancers13246226
[5]	ZHAO W， WANG L， YANG J， et al. Endothelial cell-derived MMP19 promotes pulmonary fibrosis by inducing E（nd）MT and monocyte infiltration ［J］. Cell Commun Signal， 2023， 21（1）： 56. doi:10.1186/s12964-023-01040-4 doi: 10.1186/s12964-023-01040-4
[6]	DAI C， XU P， LIU S， et al. Long noncoding RNA ZEB1-AS1 affects paclitaxel and cisplatin resistance by regulating MMP19 in epithelial ovarian cancer cells ［J］. Arch Gynecol Obstet， 2021， 303（5）： 1271-1281. doi:10.1007/s00404-020-05858-y doi: 10.1007/s00404-020-05858-y
[7]	MULLER M， BECK I M， GADESMANN J， et al. MMP19 is upregulated during melanoma progression and increases invasion of melanoma cells ［J］. Mod Pathol， 2010， 23（4）： 511-521. doi:10.1038/modpathol.2009.183 doi: 10.1038/modpathol.2009.183
[8]	LETTAU I， HATTERMANN K， HELD-FEINDT J， et al. Matrix metalloproteinase-19 is highly expressed in astroglial tumors and promotes invasion of glioma cells ［J］. J Neuropathol Exp Neurol， 2010， 69（3）： 215-223. doi:10.1097/nen.0b013e3181ce9f67 doi: 10.1097/nen.0b013e3181ce9f67
[9]	LU J， KORNMANN M， TRAUB B. Role of Epithelial to Mesenchymal Transition in Colorectal Cancer ［J］. Int J Mol Sci， 2023， 24（19）：14815. doi:10.3390/ijms241914815 doi: 10.3390/ijms241914815
[10]	SINGH M， MORRIS V K， BANDEY I N， et al. Advancements in combining targeted therapy and immunotherapy for colorectal cancer ［J］. Trends Cancer， 2024， 10（7）： 598-609. doi:10.1016/j.trecan.2024.05.001 doi: 10.1016/j.trecan.2024.05.001
[11]	PARKHURST M， GOFF S L， LOWERY F J， et al. Adoptive transfer of personalized neoantigen-reactive TCR-transduced T cells in metastatic colorectal cancer： phase 2 trial interim results ［J］. Nat Med， 2024， 30（9）： 2586-2595. doi:10.1038/s41591-024-03109-0 doi: 10.1038/s41591-024-03109-0
[12]	PITTAYAPRUEK P， MEEPHANSAN J， PRAPAPAN O， et al. Role of Matrix Metalloproteinases in Photoaging and Photocarcinogenesis ［J］. Int J Mol Sci， 2016， 17（6）：868. doi:10.3390/ijms17060868 doi: 10.3390/ijms17060868
[13]	SHOARI A， ASHJA ARDALAN A， DIMESA A M， et al. Targeting Invasion： The Role of MMP-2 and MMP-9 Inhibition in Colorectal Cancer Therapy ［J］. Biomolecules， 2024， 15（1）：35. doi:10.3390/biom15010035 doi: 10.3390/biom15010035
[14]	MENG LI M W. Expression and Clinical Characteristics of Matrix Metalloproteinases in Malignant Tu-mors ［J］. Advances in Clinical Medicine， 2022， 12（05）： 4355-60. doi:10.12677/acm.2022.125631 doi: 10.12677/acm.2022.125631
[15]	CRAIG V J， ZHANG L， HAGOOD J S， et al. Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis ［J］. Am J Respir Cell Mol Biol， 2015， 53（5）： 585-600. doi:10.1165/rcmb.2015-0020tr doi: 10.1165/rcmb.2015-0020tr
[16]	YANG C， DONG X， SUN B， et al. Physical immune escape： Weakened mechanical communication leads to escape of metastatic colorectal carcinoma cells from macrophages ［J］. Proc Natl Acad Sci U S A， 2024， 121（22）： e2322479121. doi:10.1073/pnas.2322479121 doi: 10.1073/pnas.2322479121
[17]	CHEN H， ZHAI C， XU X， et al. Multilevel Heterogeneity of Colorectal Cancer Liver Metastasis ［J］. Cancers （Basel）， 2023， 16（1）：59. doi:10.3390/cancers16010059 doi: 10.3390/cancers16010059
[18]	SHASHA T， GRUIJS M， VAN EGMOND M. Mechanisms of colorectal liver metastasis development ［J］. Cell Mol Life Sci， 2022， 79（12）： 607. doi:10.1007/s00018-022-04630-6 doi: 10.1007/s00018-022-04630-6
[19]	LIU C， QU L， ZHAO C， et al. Extracellular gamma-synuclein promotes tumor cell motility by activating beta1 integrin-focal adhesion kinase signaling pathway and increasing matrix metalloproteinase-24， -2 protein secretion ［J］. J Exp Clin Cancer Res， 2018， 37（1）： 117. doi:10.1186/s13046-018-0783-6 doi: 10.1186/s13046-018-0783-6
[20]	WANG Y， YU S J， LI Y X， et al. Expression and clinical significance of matrix metalloproteinase-17 and -25 in gastric cancer ［J］. Oncol Lett， 2015， 9（2）： 671-676. doi:10.3892/ol.2014.2747 doi: 10.3892/ol.2014.2747
[21]	XIAO C， WANG Y， CHENG Q， et al. Increased expression of MMP17 predicts poor clinical outcomes in epithelial ovarian cancer patients ［J］. Medicine （Baltimore）， 2022， 101（34）： e30279. doi:10.1097/md.0000000000030279 doi: 10.1097/md.0000000000030279
[22]	ZHANG Y， WANG J， FAN Y， et al. MMP11 and MMP17 are potential biomarkers for uterine corpus endometrial carcinoma prognosis ［J］. Clin Transl Oncol， 2024， 26（3）： 653-663. doi:10.1007/s12094-023-03284-5 doi: 10.1007/s12094-023-03284-5
[23]	YU J， HE Z， HE X， et al. Comprehensive Analysis of the Expression and Prognosis for MMPs in Human Colorectal Cancer ［J］. Front Oncol， 2021， 11： 771099. doi:10.3389/fonc.2021.771099 doi: 10.3389/fonc.2021.771099
[24]	MI T， ZHANG Z， ZHANGHUANG C， et al. Doxycycline hydrochloride inhibits the progress of malignant rhabdoid tumor of kidney by targeting MMP17 and MMP1 through PI3K-Akt signaling pathway ［J］. Eur J Pharmacol， 2024， 964： 176291. doi:10.1016/j.ejphar.2023.176291 doi: 10.1016/j.ejphar.2023.176291
[25]	YIP C， FOIDART P， SOMJA J， et al. MT4-MMP and EGFR expression levels are key biomarkers for breast cancer patient response to chemotherapy and erlotinib ［J］. Br J Cancer， 2017， 116（6）： 742-751. doi:10.1038/bjc.2017.23 doi: 10.1038/bjc.2017.23
[26]	PAOLILLO M， SCHINELLI S. Extracellular Matrix Alterations in Metastatic Processes ［J］. Int J Mol Sci， 2019， 20（19）：4947. doi:10.3390/ijms20194947 doi: 10.3390/ijms20194947
[27]	JIROUSKOVA M， ZBODAKOVA O， GREGOR M， et al. Hepatoprotective effect of MMP-19 deficiency in a mouse model of chronic liver fibrosis ［J］. PLoS One， 2012， 7（10）： e46271. doi:10.1371/journal.pone.0046271 doi: 10.1371/journal.pone.0046271

组别	细胞类型	细胞占比	MMP-19	F值	P值
肝转移灶	巨噬细胞	0.49	0.84 ± 1.04^a	1 125.38	8.08e^-234
肝转移灶旁正常组织		0.17	0.26 ± 0.66	1 125.38	8.08e^-234
原发位结直肠癌		0.22	0.41 ± 0.88^b	24.44	7.95e^-07
原发癌旁正常组织		0.15	0.27 ± 0.72	24.44	7.95e^-07
肝转移灶	树突状细胞	0.23	0.33 ± 0.72^c	190.874	7.247e^-43
肝转移灶旁正常组织		0.10	0.13 ± 0.44	190.874	7.247e^-43
原发位结直肠癌		0.23	0.33 ± 0.73^d	6.492	0.01
原发癌旁正常组织		0.15	0.21 ± 0.59	6.492	0.01

组别	复孔数	MMP-19（TPM）
Oe-MMP-19	3	806.40 ± 14.79^a
Nc-MMP-19	3	11.88 ± 1.91
Sh-MMP-19	3	0.70 ± 0.39^b

组别	复孔数	MMP?14	FN1	CDH1	SNAI1	MMP?17
Oe-MMP-19	3	43.45 ± 1.99^a	9.83 ± 0.55^b	95.83 ± 3.64^c	17.73 ± 1.04^d	22.70 ± 1.41^e
Nc-MMP-19	3	18.85 ± 2.90	3.49 ± 0.88	241.00 ± 11.81	12.25 ± 0.21	18.18 ± 1.15

组别	复孔数	MMP?24	ZEB1	MMP?17
Sh-MMP-19	3	1.81 ± 0.12^a	12.36 ± 0.82^b	12.09 ± 0.42^c
Nc-MMP-19	3	2.52 ± 0.26	15.20 ± 1.05	18.18 ± 1.15

组别	复孔数	MMP-19
T1	3	1.615 ± 0.50^a
N1	3	1.00
T2	3	3.63 ± 1.93^b
N2	3	1.00
T3	3	2.51 ± 0.74^c
N3	3	1.00
T4	3	1.03 ± 0.32^d
N4	3	1.00

The role and prognostic value of matrix metalloproteinase 19 in colorectal cancer and its liver metastasis

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 20

References 27

Related Articles 15

Recommended Articles

Metrics

Comments

组别	样本数	MMP-19
结直肠癌组织	10	8.78 ± 12.51^a
癌旁组织	10	1.01 ± 0.01

组别	复孔数	迁移细胞个数（5 ×）
Oe-MMP-19	3	471.00 ± 9.17^a
Nc-MMP-19	3	274.00 ± 32.79
Sh-MMP-19	3	118.00 ± 6.00^b

组别	复孔数	24 h	48 h	72 h
Oe-MMP-19	3	12.89 ± 1.58^a	19.67 ± 0.47^c	25.20 ± 0.80^e
Nc-MMP-19	3	12.26 ± 0.55	16.62 ± 0.25	21.69 ± 1.02
Sh-MMP-19	3	8.81 ± 2.51^b	12.99 ± 0.94^d	16.02 ± 1.29^f

组别	复孔数	24 h	48 h
Oe-MMP-19	3	13.84 ± 0.71^a	24.25 ± 0.75^b
Sh-MMP-19	3	10.80 ± 1.54	18.23 ± 2.09

组别	复孔数	克隆细胞个数
Oe-MMP-19	3	509.3 ± 24.13^a
Nc-MMP-19	3	401.3 ± 19.76
Sh-MMP-19	3	194.7 ± 50.65^b

组别	复孔数	24 h	48 h	72 h	96 h
Oe-MMP-19	3	0.45 ± 0.03^a	0.67 ± 0.01^b	1.05 ± 0.04^c	2.10 ± 0.01^d
Sh-MMP-19	3	0.37 ± 0.01	0.55 ± 0.02	0.86 ± 0.03	1.66 ± 0.02

组别	复孔数	24 h	48 h	72 h
Oe-MMP-19	3	0.56 ± 0.01^a	0.79 ± 0.02^b	1.20 ± 0.01^c
Sh-MMP-19	3	0.54 ± 0.02	0.63 ± 0.02	0.79 ± 0.01

[1]	Na WU,Zetian ZHANG,Rui WANG. The expression and clinical significance of B7⁃H3， PRDX1， and TRX in the serum and tissues of patients with ulcerative colitis and its related colorectal cancer [J]. The Journal of Practical Medicine, 2025, 41(9): 1407-1412.
[2]	Likun WANG,Qi HAO,Weihan JIN,Shizheng DONG,Xueliang WU,Xiaofeng HU,Liang WU,Jing XUN,Hongqing MA. Application of multi⁃omics and artificial intelligence in the prediction and diagnosis of liver metastases in colorectal cancer [J]. The Journal of Practical Medicine, 2025, 41(7): 1070-1078.
[3]	Linsha KONG,Gaigai HE,Ting LI,Kun FANG,Wei HE,Li WEI. Experimental study of doxorubicin coated by magnetic drug⁃carrying gel beads in the treatment of colorectal cancer [J]. The Journal of Practical Medicine, 2025, 41(7): 953-959.
[4]	Wei WANG,Min WANG,Minmin CHENG,Tingting. ZHANG. Impacts of safflower polysaccharide on tumor growth and PI3K/Akt/mTOR signal pathway in mice with colorectal cancer [J]. The Journal of Practical Medicine, 2025, 41(5): 670-675.
[5]	Jiyue ZHU,Bo ZHANG,Yaru LI,Liuye. HUANG. The predictive value of the systemic inflammation response index for non⁃curative resection after endoscopic submucosal dissection for early colorectal cancer [J]. The Journal of Practical Medicine, 2025, 41(5): 716-723.
[6]	Long WANG,Yingmin WU,Sha SHANG,Lu WANG. The diagnostic value and clinical research of 5′⁃tRF⁃GlyGCC in the early stage of colorectal cancer [J]. The Journal of Practical Medicine, 2025, 41(11): 1730-1735.
[7]	Xiao YANG,Tao WANG,Wei WANG,Yaohui PENG,Yan CHEN,Haiping ZENG,Bao YANG. Lipidomic profile of serum in colorectal cancer patients and its diagnostic significance [J]. The Journal of Practical Medicine, 2025, 41(11): 1742-1750.
[8]	Wenying SHANG,Die LONG,Haihui CHEN. Real⁃world analysis of the differences between left and right colorectal cancer based on clinical pathological characteristics and gene testing results [J]. The Journal of Practical Medicine, 2025, 41(1): 48-52.
[9]	Yuxuan DING,Lining GUO,Jiayi SHEN,Lijun. WANG. Safety and efficacy of radiotherapy and PD⁃1/PD⁃L1 inhibitor + TKI for MSS/pMMR colorectal cancer with liver metastases [J]. The Journal of Practical Medicine, 2024, 40(9): 1293-1297.
[10]	Wei DENG,Dan PENG,Haijun HU,Jing ZHANG,Shuchun YU,Song. HUANG. Application of general anesthesia under nociception index combined with BIS monitoring in laparoscopic radical resection of colorectal cancer [J]. The Journal of Practical Medicine, 2024, 40(24): 3476-3481.
[11]	Mingxin TANG,Xiaolin WANG,Xuanfei. LI. Research progress of statins in the prevention and treatment of colorectal cancer [J]. The Journal of Practical Medicine, 2024, 40(14): 2041-2046.
[12]	LI Xiaoping, ZHOU Hongjian, GAO Fangfang, LI Wei.. Tspan1 antagonizes oxaliplatin⁃induced apoptosis in colorectal cancer cells by inducing cellular autophagy [J]. The Journal of Practical Medicine, 2023, 39(9): 1072-1078.
[13]	HAO Jian, HAN Lei.. Diagnostic value of single and combined panel of serum exosomal microRNAs in colorectal cancer [J]. The Journal of Practical Medicine, 2023, 39(3): 364-373.
[14]	Haiying LIU,Feng CHEN,Jia. YAO. Suppression of miR-767-5p expression of inhibits breast cancer cell proliferation， migration， invasion and EMT through down-regulating IGF1 [J]. The Journal of Practical Medicine, 2023, 39(22): 2878-2884.
[15]	Fengshuai YANG,Dongda QIU,Yunquan YANG,Shuangxi GONG,Shilin CHEN,Xinyu. WANG. The effect of targeted regulation of miR⁃516a⁃5p by LncRNA SNHG16 on the proliferation， invasion， and migration ability of colorectal cancer cells [J]. The Journal of Practical Medicine, 2023, 39(20): 2591-2596.

组别	复孔数	侵袭细胞个数（10 ×）
Oe-MMP-19	3	272.00 ± 11.53^a
Sh-MMP-19	3	230.30 ± 4.93

组别	复孔数	迁移细胞个数（10 ×）
Oe-MMP-19	3	169.00 ± 13.23^a
Sh-MMP-19	3	35.00 ± 15.39